N/A
N=180
MINDSpeed Food and Brain Training RCT
Low Education · Cognition · Cognitive Training · Polyphenols
Bottom Line
View on ClinicalTrials.gov: NCT03419052 ↗Enrolled (actual)
180
Serious AEs
35.6%
Results posted
Mar 2025
Primary outcome: Primary: Executive Cognitive Function Composite Score — 0.211; 0.100; 0.142; 0.196 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Speed of processing training (Behavioral); MIND foods (Behavioral); Cognitive training control (Behavioral); Control foods (Behavioral)
- Age
- Adult, Older Adult · 60+ yrs
- Sex
- All
- Sponsor
- Indiana University
- Primary completion
- Mar 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Executive Cognitive Function Composite Score |
0.211; 0.100; 0.142; 0.196 | — |
Summary
The purpose of this study is to learn how foods high in polyphenols and brain training exercises affect older adults' cognitive performance
Eligibility Criteria
Inclusion criteria
- age 60 years or older,
- ≤ 12 years of education,
- English speaking,
- Marion County (and immediately surrounding counties) resident, with steady/fixed residence to receive food deliveries
- natural-born US citizen.
Exclusion criteria
- living in nursing home
- self-reported diagnosis of dementia, Alzheimer's disease (AD), cancer with short life expectancy, multiple sclerosis, epilepsy, schizophrenia, bipolar disorder, Parkinson disease; current chemotherapy or radiation therapy; history of brain tumor, brain surgery, brain infection; stroke or myocardial infarction within the past 12 months
- current alcohol consumption ≥8 drinks per week for women or ≥15 drinks per week for men;
- poor vision (self-reported difficulty reading a newspaper) or color blind;
- low communicative ability (examiner rated) that would interfere with interventions and assessments;
- prior involvement in similar cognitive training studies;
- unable or unwilling to provide blood sample at Baseline
- tumor, hemorrhage, aneurysm, hydrocephalus, or other significant clinical finding from Baseline brain MRI
Data sourced from ClinicalTrials.gov (NCT03419052). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.